CMAJ . September 28, 2004; 171 (7). Health And Drug Alerts Domperidone for lactating women Orlando P. da Silva* and David C. Knoppert Reason for posting: Domperidone has been widely used as a motility and antiemetic agent. In oral form it is also used off label to improve lactation in breast-feeding women. Intravenous domperidone has been withdrawn from the market worldwide because of reports of cardiac arrhythmia and sudden death in patients with malignant disease who received relatively high intravenous doses of the drug for nausea and vomiting induced by cytotoxic therapy... ... Domperidone has been approved for oral use in Canada and worldwide as a motility agent with an excellent safety record... ...Lactating women with decreased milk supply who are unresponsive to nonpharmacologic measures to enhance lactation, including counselling, relaxation techniques and mechanical expression, should continue to consider domperidone at antiemetic doses. continued, goto Canadian Medical Association Journal article on Highwire, http://makeashorterlink.com/?F4212167B *********************************************** To temporarily stop your subscription: set lactnet nomail To start it again: set lactnet mail (or digest) To unsubscribe: unsubscribe lactnet All commands go to [log in to unmask] The LACTNET mailing list is powered by L-Soft's renowned LISTSERV(R) list management software together with L-Soft's LSMTP(R) mailer for lightning fast mail delivery. For more information, go to: http://www.lsoft.com/LISTSERV-powered.html